Cargando…
Immune-Based Therapy for Hospitalized Patients With COVID-19 and Risk of Secondary Infections: A Systematic Review and Meta-analysis
BACKGROUND: Immune-based therapies are standard-of-care treatment for coronavirus disease 2019 (COVID-19) patients requiring hospitalization. However, safety concerns related to the potential risk of secondary infections may limit their use. METHODS: We searched OVID Medline, Ovid EMBASE, SCOPUS, Co...
Autores principales: | Kabbani, Dima, Sonpar, Ashlesha, Weyant, Benson, Lau, Keith C K, Robbins, Mark, Campbell, Sandra, Doucette, Karen, Abraldes, Juan G, Lotfi, Tamara, Chaktoura, Marlene, Akl, Elie A, Cervera, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825199/ https://www.ncbi.nlm.nih.gov/pubmed/36628058 http://dx.doi.org/10.1093/ofid/ofac655 |
Ejemplares similares
-
2111. Impact of Colonization by Multi Drug Resistant Bacteria on Graft Survival, Risk of Infection, and Mortality in Recipients of Solid Organ Transplant: Systematic Review and Meta-analysis
por: Almohaya, Abdulellah, et al.
Publicado: (2022) -
2104. Cytomegalovirus DNAemia Patterns in Mismatched Solid Organ Transplant Recipients: A Retrospective Cohort Study.
por: Garcia, Oscar A Fernandez, et al.
Publicado: (2022) -
Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19: A protocol for a pragmatic clinical trial
por: Chen, Justin Z., et al.
Publicado: (2022) -
2646. Incidence of Myelosuppression Related to Valganciclovir Prophylaxis in Solid-Organ Transplant Recipients at High Risk of CMV Disease
por: Belga, Sara, et al.
Publicado: (2019) -
1722. Histoplasmosis Acquired in Alberta, Canada, 2011–2018
por: Dingle, Tanis, et al.
Publicado: (2019)